Xuwei Hou
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- DNA Repair Mechanisms 2
- Metabolism, Diabetes, and Cancer 2
- Surgery 6
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
- Co-authors
- Heng Zeng (4 shared papers)Jian‐Xiong Chen (4 shared papers)Xiaochen He (3 shared papers)Ningfu Wang (8 shared papers)Lanfang Li (2 shared papers)Meili Lü (4 shared papers)Zhaohui Hu (5 shared papers)Xiuying He (4 shared papers)
- Journals
- Cellular Physiology and Biochemistry (5 papers)Medicine (3 papers)The FASEB Journal (2 papers)PLoS ONE (2 papers)American Journal of Physiology-Heart and Circulatory Physiology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xuwei Hou
37 papers receiving 979 citations
Peers
Comparison fields: 5 of 79
- Geriatrics and Gerontology 69
- Clinical Biochemistry 85
- Pharmacology 167
- Complementary and alternative medicine 61
- Cardiology and Cardiovascular Medicine 148
Countries citing papers authored by Xuwei Hou
This map shows the geographic impact of Xuwei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuwei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuwei Hou more than expected).
Fields of papers citing papers by Xuwei Hou
This network shows the impact of papers produced by Xuwei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuwei Hou. The network helps show where Xuwei Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuwei Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 139 | |
| 2 | 2013 | 102 | |
| 3 | 2014 | 68 | |
| 4 | 2018 | 65 | |
| 5 | 2013 | 61 | |
| 6 | 2015 | 44 | |
| 7 | 2020 | 39 | |
| 8 | 2009 | 33 | |
| 9 | 2013 | 31 | |
| 10 | 2005 | 31 | |
| 11 | 2018 | 28 | |
| 12 | 2020 | 27 | |
| 13 | 2007 | 24 | |
| 14 | 2012 | 22 | |
| 15 | 2013 | 19 | |
| 16 | 2020 | 19 | |
| 17 | 2009 | 19 | |
| 18 | 2017 | 18 | |
| 19 | 2010 | 18 | |
| 20 | 2021 | 17 |
About Xuwei Hou
Xuwei Hou is a scholar working on Molecular Biology, Surgery, Cardiology and Cardiovascular Medicine, Pharmacology and Physiology, having authored 37 papers that have together received 991 indexed citations. Recurring topics across this work include Apelin-related biomedical research (5 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Lipid metabolism and disorders (4 papers), Bone and Dental Protein Studies (3 papers), Advanced Glycation End Products research (3 papers), DNA Repair Mechanisms (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). The work is most often cited by research in Geriatrics and Gerontology (69 citations), Clinical Biochemistry (85 citations), Pharmacology (167 citations), Complementary and alternative medicine (61 citations) and Cardiology and Cardiovascular Medicine (148 citations). Xuwei Hou has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Heng Zeng, Jian‐Xiong Chen, Xiaochen He, Ningfu Wang, Lanfang Li, Meili Lü, Zhaohui Hu, Xiuying He, Yigang Zhong and Bo Yin. Their work appears in journals such as Cellular Physiology and Biochemistry, Medicine, The FASEB Journal, PLoS ONE and American Journal of Physiology-Heart and Circulatory Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.